The NPV of ACHN's HCV program (licensed to JNJ) is de minimis. When evaluating ACHN as a potential investment, you can you can ignore HCV, for all practical purposes.
“The efficient-market hypothesis may be the foremost piece of B.S. ever promulgated in any area of human knowledge!”
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.